Report Detail

Request for Sample of this report

Other Global Generic Injectable Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4619073
    • |
  • 26 September, 2024
    • |
  • Global
    • |
  • 117 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
According to our (Global Info Research) latest study, the global Generic Injectable Drugs market size was valued at US$ 32690 million in 2023 and is forecast to a readjusted size of USD 41260 million by 2030 with a CAGR of 3.4% during review period.
In the segment of generic sterile injectable drugs, the Hospira (Pfizer Inc.) is the largest player, and Fresenius Kabi is the second. Top two players hold a share about 27% in 2019. The US market is dominated by two players like Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, Gland Pharma and Endo International PLC.
This report is a detailed and comprehensive analysis for global Generic Injectable Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Generic Injectable Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
Global Generic Injectable Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Generic Injectable Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Generic Injectable Drugs market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Generic Injectable Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Generic Injectable Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Auromedics, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Generic Injectable Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Generic Injectable Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Small Molecule
Large Molecule
Market segment by Application
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Market segment by players, this report covers
Hospira (Pfizer Inc.)
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Generic Injectable Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Generic Injectable Drugs, with revenue, gross margin, and global market share of Generic Injectable Drugs from 2019 to 2024.
Chapter 3, the Generic Injectable Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Generic Injectable Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Generic Injectable Drugs.
Chapter 13, to describe Generic Injectable Drugs research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Generic Injectable Drugs by Type
    • 1.3.1 Overview: Global Generic Injectable Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Generic Injectable Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Small Molecule
    • 1.3.4 Large Molecule
  • 1.4 Global Generic Injectable Drugs Market by Application
    • 1.4.1 Overview: Global Generic Injectable Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Oncology
    • 1.4.3 Anesthesia
    • 1.4.4 Anti-Infectives
    • 1.4.5 Parenteral Nutrition
    • 1.4.6 Cardiovascular Diseases
  • 1.5 Global Generic Injectable Drugs Market Size & Forecast
  • 1.6 Global Generic Injectable Drugs Market Size and Forecast by Region
    • 1.6.1 Global Generic Injectable Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Generic Injectable Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Generic Injectable Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Generic Injectable Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Generic Injectable Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Generic Injectable Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Generic Injectable Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Hospira (Pfizer Inc.)
    • 2.1.1 Hospira (Pfizer Inc.) Details
    • 2.1.2 Hospira (Pfizer Inc.) Major Business
    • 2.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Product and Solutions
    • 2.1.4 Hospira (Pfizer Inc.) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Hospira (Pfizer Inc.) Recent Developments and Future Plans
  • 2.2 Fresenius Kabi
    • 2.2.1 Fresenius Kabi Details
    • 2.2.2 Fresenius Kabi Major Business
    • 2.2.3 Fresenius Kabi Generic Injectable Drugs Product and Solutions
    • 2.2.4 Fresenius Kabi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Fresenius Kabi Recent Developments and Future Plans
  • 2.3 Sandoz (Novartis)
    • 2.3.1 Sandoz (Novartis) Details
    • 2.3.2 Sandoz (Novartis) Major Business
    • 2.3.3 Sandoz (Novartis) Generic Injectable Drugs Product and Solutions
    • 2.3.4 Sandoz (Novartis) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sandoz (Novartis) Recent Developments and Future Plans
  • 2.4 Hikma Pharmaceuticals PLC
    • 2.4.1 Hikma Pharmaceuticals PLC Details
    • 2.4.2 Hikma Pharmaceuticals PLC Major Business
    • 2.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Product and Solutions
    • 2.4.4 Hikma Pharmaceuticals PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Hikma Pharmaceuticals PLC Recent Developments and Future Plans
  • 2.5 Dr. Reddy’s Laboratories Ltd
    • 2.5.1 Dr. Reddy’s Laboratories Ltd Details
    • 2.5.2 Dr. Reddy’s Laboratories Ltd Major Business
    • 2.5.3 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Product and Solutions
    • 2.5.4 Dr. Reddy’s Laboratories Ltd Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans
  • 2.6 Grifols
    • 2.6.1 Grifols Details
    • 2.6.2 Grifols Major Business
    • 2.6.3 Grifols Generic Injectable Drugs Product and Solutions
    • 2.6.4 Grifols Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Grifols Recent Developments and Future Plans
  • 2.7 Nichi-Iko Group (Sagent)
    • 2.7.1 Nichi-Iko Group (Sagent) Details
    • 2.7.2 Nichi-Iko Group (Sagent) Major Business
    • 2.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Product and Solutions
    • 2.7.4 Nichi-Iko Group (Sagent) Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Nichi-Iko Group (Sagent) Recent Developments and Future Plans
  • 2.8 Teva Pharmaceutical
    • 2.8.1 Teva Pharmaceutical Details
    • 2.8.2 Teva Pharmaceutical Major Business
    • 2.8.3 Teva Pharmaceutical Generic Injectable Drugs Product and Solutions
    • 2.8.4 Teva Pharmaceutical Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Teva Pharmaceutical Recent Developments and Future Plans
  • 2.9 Auromedics
    • 2.9.1 Auromedics Details
    • 2.9.2 Auromedics Major Business
    • 2.9.3 Auromedics Generic Injectable Drugs Product and Solutions
    • 2.9.4 Auromedics Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Auromedics Recent Developments and Future Plans
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Generic Injectable Drugs Product and Solutions
    • 2.10.4 Sanofi Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sanofi Recent Developments and Future Plans
  • 2.11 Gland Pharma
    • 2.11.1 Gland Pharma Details
    • 2.11.2 Gland Pharma Major Business
    • 2.11.3 Gland Pharma Generic Injectable Drugs Product and Solutions
    • 2.11.4 Gland Pharma Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Gland Pharma Recent Developments and Future Plans
  • 2.12 Endo International PLC
    • 2.12.1 Endo International PLC Details
    • 2.12.2 Endo International PLC Major Business
    • 2.12.3 Endo International PLC Generic Injectable Drugs Product and Solutions
    • 2.12.4 Endo International PLC Generic Injectable Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Endo International PLC Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Generic Injectable Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Generic Injectable Drugs by Company Revenue
    • 3.2.2 Top 3 Generic Injectable Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Generic Injectable Drugs Players Market Share in 2023
  • 3.3 Generic Injectable Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Generic Injectable Drugs Market: Region Footprint
    • 3.3.2 Generic Injectable Drugs Market: Company Product Type Footprint
    • 3.3.3 Generic Injectable Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Generic Injectable Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Generic Injectable Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Generic Injectable Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Generic Injectable Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Generic Injectable Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Generic Injectable Drugs Market Size by Application (2019-2030)
  • 6.3 North America Generic Injectable Drugs Market Size by Country
    • 6.3.1 North America Generic Injectable Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Generic Injectable Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Generic Injectable Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Generic Injectable Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Generic Injectable Drugs Market Size by Country
    • 7.3.1 Europe Generic Injectable Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Generic Injectable Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Generic Injectable Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Generic Injectable Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Generic Injectable Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Generic Injectable Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Generic Injectable Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Generic Injectable Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Generic Injectable Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Generic Injectable Drugs Market Size by Country
    • 9.3.1 South America Generic Injectable Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Generic Injectable Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Generic Injectable Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Generic Injectable Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Generic Injectable Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Generic Injectable Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Generic Injectable Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Generic Injectable Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Generic Injectable Drugs Market Drivers
  • 11.2 Generic Injectable Drugs Market Restraints
  • 11.3 Generic Injectable Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Generic Injectable Drugs Industry Chain
  • 12.2 Generic Injectable Drugs Upstream Analysis
  • 12.3 Generic Injectable Drugs Midstream Analysis
  • 12.4 Generic Injectable Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Generic Injectable Drugs. Industry analysis & Market Report on Generic Injectable Drugs is a syndicated market report, published as Global Generic Injectable Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Generic Injectable Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,599.56
    		3,899.34
    		5,199.12
    		3,118.08
    		4,677.12
    		6,236.16
    		496,944.00
    		745,416.00
    		993,888.00
    		291,310.80
    		436,966.20
    		582,621.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo